Viral illness in older adults has always carried risk—but the conversation is shifting. Emerging research continues to reinforce that viruses like influenza, COVID-19, RSV, and even shingles are not isolated events. They are catalysts for broader clinical decline, including cardiovascular events, functional deterioration, and hospitalization.

At the same time, gaps in vaccination programs—particularly in nursing homes and assisted living—are creating measurable differences in outcomes across care settings.

For operators and clinicians, the takeaway is clear: infection prevention is no longer just about avoiding outbreaks. It’s about protecting long-term health, stability, and cost.

The Hidden Risk: Infection as an Outcome Trigger

Recent research has found that vaccination may play a protective role far beyond infection prevention.

A study published in the European Heart Journal found that shingles vaccination was associated with a significantly lower risk of major cardiovascular events, including stroke and heart attack, for up to eight years after vaccination.

And high-dose flu vaccination has been associated with decreased risk of Alzheimer’s among older adults.

Meanwhile, RSV infection has been linked to increased risk of acute cardiovascular events in older adults, including heart attack and stroke.

These findings reinforce a growing understanding: infections act as physiological stressors that can destabilize already vulnerable systems.

For senior care providers, this reframes vaccination as a strategy not just for infection control—but for reducing downstream clinical events that drive hospitalizations, health decline, and cost.

Why Older Adults Are More Vulnerable Than Ever

New research published in Immunity highlights why respiratory viruses continue to hit older adults harder. Aging lung cells show impaired immune responses, making it more difficult to clear infections and increasing the likelihood of severe illness.

This aligns with what providers are seeing on the ground: higher acuity, more complex residents, and less physiological reserve.

Layer on emerging COVID variants—such as newer strains currently circulating—and the risk environment becomes even more dynamic.

At the same time, RSV seasons are extending beyond traditional timelines, increasing exposure risk across longer periods.

The operational implication is simple: the old “seasonal” approach to respiratory illness is no longer sufficient.

Vaccination Gaps Are Creating Outcome Gaps

Although nursing homes had achieved relatively strong participation in vaccination programs previously, a recent study found that only 3 in 5 nursing home residents received the flu vaccine last year. Meanwhile, assisted living communities have continued to lag behind in vaccination participation in general.

Data shows that lower vaccination program participation in assisted living is associated with higher rates of hospitalization.

This is not just a clinical issue—it’s an operational and financial one.

Higher hospitalization rates mean:

• Increased disruption to resident stability
• Greater strain on staff and care coordination
• Elevated risk exposure tied to quality metrics and reimbursement

This highlights a key opportunity: standardizing and strengthening vaccination strategies across all levels of senior care.

Taken together, these trends are changing how risk is identified, managed, and measured across senior care settings.

How This Changes Day-to-Day Clinical Strategy

It’s no wonder that infection control still dominates surveyor’s attention. This is no longer just about managing outbreaks after they occur.

It requires a more integrated, proactive approach that connects infection prevention to broader clinical outcomes. That includes:

• Treating vaccination as a core component of chronic disease and cardiovascular risk management
• Moving beyond seasonal planning to year-round vigilance
• Closing program gaps between care settings—especially in assisted living
• Leveraging every clinical touchpoint to assess and update vaccination status

The organizations that do this well are not just preventing infections—they are stabilizing residents, reducing hospitalizations, and protecting long-term outcomes.

Where This Shows Up in Resident Outcomes

Respiratory viruses are rarely isolated events in senior care—they often trigger a cascade of clinical decline.

When prevention strategies are inconsistent or delayed, the impact shows up quickly in resident outcomes:

• Increased hospital transfers
• Faster functional decline
• Greater complexity in medication and care management
• Higher risk of long-term complications

Conversely, communities with strong, consistent vaccination and clinical coordination see more stability—fewer disruptions, better recovery trajectories, and improved overall quality of care.

Forum partners with providers to simplify that complexity—bringing accuracy, responsiveness, and the clinical coordination needed to keep residents stable.